GlobeNewsWire · FATE · October 26, 2026

Fate Therapeutics Presents Updated Preliminary Data for FT819 in Active Lupus Nephritis at American Society of Nephrology Kidney Week 2026

Get the app for more

Explore stock news, insights and company research.